Adia Med, Inc.

Adia Med, Inc.

OOTC:ADIA
0.13
USD
+0.01
(+7.56%)
0.00EPS
14.54MMarket Cap

Total Valuation

USD

As of June 30, 2026, Adia Med, Inc. carries a market capitalization of 14.54M, placing it among publicly traded companies globally. Its enterprise value stands at 15.41M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap14.54M
Enterprise Value15.41M

Share Statistics

As of June 30, 2026, Adia Med, Inc. has 94.40M shares outstanding.

Shares Outstanding94.40M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 13.35, and the price-to-book ratio stands at -38.11.

PS Ratio13.35
PB Ratio-38.11
P/TBV Ratio-38.11
P/FCF Ratio-94.44
P/OCF Ratio-82.71

Enterprise Valuation

These figures are as of June 30, 2026. The EV/Sales ratio of 14.14 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 15.41M versus a market cap of 14.54M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales14.14

Financial Position

As of June 30, 2026, Adia Med, Inc. maintains a current ratio of 0.32, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -261.67, indicating conservative leverage, while an interest coverage ratio of -3.46 demonstrates limited ability to service its debt obligations.

Current Ratio0.32
Quick Ratio0.16
Debt / Equity-261.67
Debt / EBITDA-6.95
Interest Coverage-3.46

Financial Efficiency

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -36.68, reflecting losses generated across the asset base. Inventory turnover of 4.14 indicates how many times Adia Med, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-36.68
Inventory Turnover4.14

Stock Price Statistics

USD

As of the close on November 13, 2026, Adia Med, Inc.'s stock has gained approximately 184.44% over the past 52 weeks. The 50-day moving average sits at 0.13, while the 200-day moving average is 0.14.

52-Week Price Change184.44%
50-Day Moving Average0.13
200-Day Moving Average0.14

Income Statement

USD

Over the twelve months ended June 30, 2026, Adia Med, Inc. generated 1.09M in revenue and converted that into -265,893.00 in net income, yielding earnings per share of 0.00. EBITDA reached -142,912.00, while operating income came in at -228,134.00.

Revenue1.09M
Gross Profit509,552.00
Operating Income-228,134.00
Pretax Income-265,893.00
Net Income-265,893.00
EBITDA-142,912.00
EBIT-227,991.00

Balance Sheet

USD

As of June 30, 2026, Adia Med, Inc. holds 128,115.00 in cash and equivalents against 993,777.00 in total debt, resulting in a net debt position of 707,197.00. Total book value stands at -381,532.00, with working capital of -714,299.00 providing operational flexibility.

Cash & Cash Equivalents128,115.00
Total Debt993,777.00
Net Debt707,197.00
Equity (Book Value)-381,532.00
Working Capital-714,299.00

Cash Flow

USD

Adia Med, Inc. produced -175,765.00 in operating cash flow over the twelve months ended June 30, 2026. After subtracting -5,496.00 in capital expenditures, free cash flow totaled -181,261.00 - equivalent to 0.00 per share.

Operating Cash Flow-175,765.00
Capital Expenditures-5,496.00
Free Cash Flow-181,261.00

Margins

Over the twelve months ended June 30, 2026, Adia Med, Inc. posted a gross margin of 46.77, reflecting its pricing power and cost economics. The operating margin of -20.94 and net profit margin of -24.41 provide insight into operational efficiency.

Gross Margin46.77
Operating Margin-20.94
Pretax Margin-24.41
Profit Margin-24.41
EBITDA Margin-13.12

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -1.06: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -1.48, meaning Adia Med, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-1.48
FCF Yield-1.06

Stock Splits

Adia Med, Inc.'s most recent stock split took place on March 17, 2004 with a 2:15 split ratio.

Last Split Date3/17/2004
Split Ratio2:15

Scores

As of June 30, 2026, Adia Med, Inc. has an Altman Z-Score of -23.22, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-23.22